Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Nasopharyngeal Carcinoma 20Carcinoma, Non-Small-Cell Lung 18Esophageal Squamous Cell Carcinoma 15Breast Neoplasms 14Triple Negative Breast Neoplasms 13Squamous Cell Carcinoma of Head and Neck 11Carcinoma, Hepatocellular 11Stomach Neoplasms 8Small Cell Lung Carcinoma 8Uterine Cervical Neoplasms 6Recurrence 6Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Transitional Cell 5Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Neoplasm Metastasis 4Melanoma 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Locally Advanced Rectal Cancer 3Liver Neoplasms 3Turcot syndrome 2Pathologic Complete Response 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2

Interventions

Carboplatin 6durvalumab 3atezolizumab 3Paclitaxel 2Bevacizumab 2toripalimab 1sintilimab 1pegylated granulocyte colony-stimulating factor 1necitumumab 1ceralasertib 1cemiplimab 1apatinib 1alectinib 1Radiotherapy 1Radiosurgery 1Pemetrexed 1Gemcitabine 1Etoposide 1Erlotinib Hydrochloride 1Cisplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Thoracic Neoplasms × toripalimab × Clear all
NCT04725448 2021-04-06

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown
27 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡